Hemoglobin A1c Monitoring : Market Research Report

Hemoglobin A1c Monitoring

Published by: Global Industry Analysts

Published: Oct. 1, 2008 - 239 Pages

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS: Study Reliability and Reporting Limitations; Disclaimers; Quantitative Techniques & Analytics; HbA1c Laboratory Testing; HbA1c Point of Care Testing & Self-Monitoring
II. EXECUTIVE SUMMARY: 1. Market Overview; Current and Future Analysis; Higher Levels of Glycosylated Hemoglobin Increases the Risk of Death; 2. Product Overview; Product Definition; Interpreting HbA1c Test Readings; Result of Hemoglobin A1c Test; The Diabetes Control & Complications Trial (DCCT); Glycated Protein Testing; HbA1c Laboratory Testing; HbA1c Point of Care Testing & Self-Monitoring; POCT & Self-Monitoring Product Developments: (2000-2003); 3. Diabetes - A Brief Profile of the Disease; What Causes Diabetes; Major Types of Diabetes; Retinopathy (Damage to the Eye and Blindness); Blood Glucose Level Guidelines* in the US; Prevalence of Diabetes in Various Parts of the World; Therapeutic Options for Diabetes; Table 5: Diabetes Treatment Options in the US: Percentage Breakdown for Insulin or Insulin & Oral Drugs, Oral Drugs, and Diet & Exercise (includes corresponding Graph/Chart); 4. Research and Development Highlights; G5 Diabetes Diagnostic Test by Provalis; 5. Technological Developments; New Noninvasive Monitoring and Testing Devices; 6. Regulatory Environment; Animas Obtains FDA Approval for OneTouch Glucose Management System; Trinity Biotech Obtains FDA Approval for Point of Care HbA1c Test; Diazyme’s Direct Enzymatic HbA1c Assay Kit Receives FDA Clearance; Axis-Shield Obtains NGSP Accreditation for Afinion HbA1c Test; FDA Approves OTC Diabetes Test and Clears Metrika’s A1cNow™ Diabetes Monitor for Home; FDA Level 1 Certification for SimpleChoice A1c Test Device; Metrika Obtains FDA Approval for Digital Response® HbA1c Patient Monitor; 7. Product Innovations/Introductions; Quantimetrix Develops GlycoHemosure; Bio-Rad Introduces The in2it Analyzer; ARKRAY Introduces PocketChem™EZ Blood Glucose Monitoring System; Nova Biomedical Launches Nova Max™ Blood Glucose Monitoring System; Abbot Introduces AlphaTRAK™ for Canines and Felines with Diabetes; OrSense Introduces Non-Invasive Hematocrit/ Hemoglobin Sensor; 8. Product Introductions in Recent Past; Axis-Shield Introduces NycoCard HbA1c Control; Beckton Launches FDA Approved Products for Diabetes Management; Cholestech Obtains Clearance to Market Cholestech GDX™ System in Canada; Integrated Technologies Launched ABAKA to Measure Glib; 9. Recent Industry Activity; Roche Inks Marketing Agreement with Mankind Pharma; Sysmex America and Bio-Rad Sign Long-term Distribution Agreement; HemoCue and Cardinal Health Sign Distribution Agreement; Abbott to Establish a New Production Facility in Donegal Town; Bio-Rad Acquires Provalis Medical Diagnostics Business; 10. Strategic Corporate Developments in Recent Past; Trinity Biotech Acquires Primus Corp; Becton Dickinson Diversifies into Blood-Glucose Meter Products; Cholestech Signs Global Distribution Agreement with Provalis; Axis-Shield Plc Acquires Nycomed Diagnostics; 11. Focus on Select Global Players; Abbott Laboratories (USA); Beckman Coulter, Inc. (US); Bio-Rad Laboratories Inc (USA); Primus Diagnostics (USA); 12. Global Market Perspective; Table 6: World Recent Past, Current and Future Analysis for HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), the Middle East, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart); Table 7: World Long-Term Projections for HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), the Middle East, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 8: World 10-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), the Middle East and Latin America and Rest of World Markets for Years 2003, 2008, 2012 (includes corresponding Graph/Chart); By Test Types; Table 9: World Recent Past, Current and Future Analysis for HbA1c Laboratory Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), the Middle East and Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart); Table 10: World Long-Term Projections for HbA1c Laboratory Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), the Middle East, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 11: World 10-Year Perspective for HbA1c Laboratory Testing by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), the Middle East and Latin America and Rest of World Markets for Years 2003, 2008, 2012 (includes corresponding Graph/Chart); Table 12: World Recent Past, Current and Future Analysis for HbA1c Point of Care and Self-Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), the Middle East and Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart); Table 13: World Long-Term Projections for HbA1c Point of Care and Self-Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), the Middle East, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 14: World 10-Year Perspective for HbA1c Point of Care and Self-Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), the Middle East and Latin America and Rest of World Markets for Years 2003, 2008, 2012 (includes corresponding Graph/Chart)
III. MARKET: 1. The United States; A. Market Overview; Challenges in the HbA1c Monitoring Market in the US; Table 16: US HbA1c Laboratory Testing Market (2006 & 2007): Percentage Breakdown of Revenues for Major Players - Bio-Rad, Roche Diagnostics, Tosoh and Others (includes corresponding Graph/Chart); Prevalence by Race/Ethnicity; Diabetes Statistics in the Recent Past - A Review; Market Trends & Issues; Impact of Diabetes Education Campaigns on HbA1c Monitors Usage; A1c Kits Available in the US; The US Clinical Laboratory Services Testing Market - A Historical; Regulatory Guidelines & Approvals; Product Innovations/Introductions; Recent Industry Activity; Key US Players; B. Market Analytics; Table 25: US 10-Year Perspective for HbA1c Monitoring by Test Type- Percentage Breakdown of Dollar Sales for HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets for 2003, 2008, 2012; 2. Canada; A. Market Overview; Strategic Developments; B. Market Analytics; Table 29: Canadian Long-Term Projections for HbA1c Monitoring by Test Type - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); 3. Japan; A. Market Overview; Key Player; Table 32: Japanese Long-Term Projections for HbA1c Monitoring by Test Type - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); 4. Europe; A. Market Overview; Table 34: Prevalence Estimates of Diabetes Mellitus in Europe: 2000 - 01 (Historic Data); Table 35: Prevalence Estimates of Type 1 Diabetes Mellitus in Europe: 2000 - 01; B. Market Analytics; Table 37: European Long-Term Projections for HbA1c Monitoring by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 38: European 10-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2003, 2008, 2012 (includes corresponding Graph/Chart); Table 39: European Recent Past, Current and Future Analysis for HbA1c Monitoring by Test Type - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart); Table 40: European Long-Term Projections for HbA1c Monitoring by Test Type - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); 4a. France; Market Overview; 4b. Germany; A. Market Overview; Strategic Corporate Developments; B. Market Analytics; Table 45: German Recent Past, Current and Future Analysis for HbA1c Monitoring by Test Type - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart); Table 46: German Long-Term Projections for HbA1c Monitoring by Test Type - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 47: German 10-Year Perspective for HbA1c Monitoring by Test Type- Percentage Breakdown of Dollar Sales for HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets for 2003, 2008, 2012; 4c. Italy; Market Overview; Table 49: Italian Long-Term Projections for HbA1c Monitoring by Test Type - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); 4d. The United Kingdom; A. Market Overview; Recent Industry Activity; Key Players; B. Market Analytics; Table 52: UK Long-Term Projections for HbA1c Monitoring by Test Type - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 53: UK 10-Year Perspective for HbA1c Monitoring by Test Type- Percentage Breakdown of Dollar Sales for HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets for 2003, 2008, 2012; 4e. Spain; Market Overview; Table 55: Spanish Long-Term Projections for HbA1c Monitoring by Test Type - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 56: Spanish 10-Year Perspective for HbA1c Monitoring by Test Type- Percentage Breakdown of Dollar Sales for HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets for 2003, 2008, 2012; 4f. Russia; Market Overview; Table 58: Russian Long-Term Projections for HbA1c Monitoring by Test Type - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 59: Russian 10-Year Perspective for HbA1c Monitoring by Test Type- Percentage Breakdown of Dollar Sales for HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets for 2003, 2008, 2012; 4g. Rest of Europe; A. Market Overview; Industry Activity in the Recent Past; B. Market Analytics; Table 61: Rest of Europe Long-Term Projections for HbA1c Monitoring by Test Type - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 62: Rest of Europe 10-Year Perspective for HbA1c Monitoring by Test Type- Percentage Breakdown of Dollar Sales for HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets for 2003, 2008, 2012; 5. Asia-Pacific; A. Market Overview; Table 63: Prevalence Estimates of Diabetes Mellitus in South-East Asia: 2000 - 01 (Historic Data); Table 65: Prevalence Estimates of Diabetes Mellitus in Western Pacific: 2000 - 01 (Historic Data); B. Market Analytics; Table 67: Asia-Pacific Long-Term Projections for HbA1c Monitoring by Test Type - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); 6. The Middle East; A. Market Overview; Table 70: Prevalence Estimates of Type 1 Diabetes Mellitus in the Middle East in 2000 - 01 (Historic Data); B. Market Analytics; Table 71: Middle East Recent Past, Current and Future Analysis for HbA1c Monitoring by Test Types - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart); Table 72: Middle East Long-Term Projections for HbA1c Monitoring by Test Type - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 73: Middle East 10-Year Perspective for HbA1c Monitoring by Test Type- Percentage Breakdown of Dollar Sales for HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets for 2003, 2008, 2012; 7. Latin America; A. Market Overview; Table 75: Prevalence Estimates of Diabetes Mellitus in South & Central America: 2000 - 01 (Historic Data); Table 76: Prevalence Estimates of Type 1 Diabetes Mellitus in South & Central America: 2000 - 01 (Historic Data); Mexico; Table 77: Prevalence Estimates of Diabetes Mellitus in Mexico: 2000 - 01 (Historic Data); Table 78: Prevalence Estimates of Type 1 Diabetes Mellitus in Mexico: 2000 - 01 (Historic Data); B. Market Analytics; Table 79: Latin American Recent Past, Current and Future Analysis for HbA1c Monitoring by Test Type - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart); Table 80: Latin American Long-Term Projections for HbA1c Monitoring by Test Type - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 81: Latin American 10-Year Perspective for HbA1c Monitoring by Test Type- Percentage Breakdown of Dollar Sales for HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets for 2003, 2008, 2012; 8. Rest of World; A. Market Overview; Diabetes Prevalence Rates in Africa; B. Market Analytics; Table 85: Rest of World Long-Term Projections for HbA1c Monitoring by Test Type - HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 86: Rest of World 10-Year Perspective for HbA1c Monitoring by Test Type- Percentage Breakdown of Dollar Sales for HbA1c Laboratory Testing and HbA1c Point of Care and Self-Monitoring Markets for 2003, 2008, 2012
IV. COMPETITIVE LANDSCAPE: Total Companies Profiled: 39 (including Divisions/Subsidiaries - 48); Region/Country Players; The United States32; Japan 3; Europe 10; Germany2; The United Kingdom 4; Italy 1; Rest of Europe 3; Asia-Pacific (Excluding Japan)2; Middle East 1

Abstract

This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ Million. The specific Test Types analyzed are HbA1c Laboratory Testing, and HbA1c Point of Care Testing & Self-Monitoring. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 39 companies including many key and niche players worldwide such as Abbott Laboratories, Axis-Shield, Bayer Healthcare Diabetes Care, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Biosafe Laboratories, Inc., Diabetes Technologies, Inc., Flexsite Diagnostics, Inc., Primus Diagnostics, Roche Diagnostics, and Tosoh Bioscience, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Titles available via "online download" are not affected by this and are still delivered to your reading room immediately.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Hemoglobin A1c Monitoring

Table of Contents

Abstract